Enzyme replacement therapy in Fabry disease in Poland: a position statement

Pol Arch Intern Med. 2020 Jan 31;130(1):91-97. doi: 10.20452/pamw.15117. Epub 2019 Dec 20.
No abstract available

MeSH terms

  • Enzyme Replacement Therapy*
  • Fabry Disease / drug therapy*
  • Female
  • Humans
  • Male
  • Poland
  • Practice Guidelines as Topic
  • alpha-Galactosidase / therapeutic use*

Substances

  • alpha-Galactosidase